CLINICAL_TRIALS
research
· 2026-04-20
Clinical Trial Update: A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Summary
A non-interventional study in Germany is currently recruiting participants with indolent systemic mastocytosis to collect observational data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Blueprint Medicines Corporation | Conditions: Indolent Systemic Mastocytosis | Status: RECRUITING